Skip to content
Screener

LENZ Therapeutics, Inc. LENZ Q2 2026 earnings

Reported August 11, 2026 · After market close

Revenue$5.5MBeat by $3.1M
EPS-$1.02Beat by $0.03
Revenue estimate$2.4M
EPS estimate-$1.05

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$4.5M
EPS estimate-$1.02

FAQ

When did LENZ Therapeutics, Inc. report Q2 2026 earnings?
LENZ Therapeutics, Inc. (LENZ) reported Q2 2026 earnings on August 11, 2026 after market close.
What were LENZ Therapeutics, Inc.'s Q2 2026 revenue and EPS?
LENZ Therapeutics, Inc. reported revenue of $5.5M and eps of $-1.02 for Q2 2026.
Did LENZ Therapeutics, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $2.4M by $3.1M. EPS beat the consensus estimate of $-1.05 by $0.03.
How did LENZ Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 9.7% from $5.0M a year earlier and eps declined 92.5% from $-0.53.
Where can I find LENZ Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001815776-26-000051) and the 10-Q periodic report (0001815776-26-000052) directly on SEC EDGAR. The filing index links above go to sec.gov.